WAC
Basic information
Region (hg38): 10:28532493-28623112
Links
Phenotypes
GenCC
Source:
- DeSanto-Shinawi syndrome due to WAC point mutation (Strong), mode of inheritance: AD
- DeSanto-Shinawi syndrome due to WAC point mutation (Supportive), mode of inheritance: AD
- DeSanto-Shinawi syndrome due to WAC point mutation (Strong), mode of inheritance: AD
- DeSanto-Shinawi syndrome due to WAC point mutation (Definitive), mode of inheritance: AD
- DeSanto-Shinawi syndrome (Definitive), mode of inheritance: AD
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| DeSanto-Shinawi syndrome | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Gastrointestinal; Neurologic; Ophthalmologic | 25356899; 26264232 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (193 variants)
- DeSanto-Shinawi_syndrome_due_to_WAC_point_mutation (82 variants)
- Inborn_genetic_diseases (68 variants)
- not_specified (20 variants)
- WAC-related_disorder (19 variants)
- DeSanto-Shinawi_syndrome (6 variants)
- Intellectual_disability (5 variants)
- See_cases (4 variants)
- Neurodevelopmental_disorder (2 variants)
- WAC-related_neurodevelopmental_disorder (1 variants)
- Neurodevelopmental_delay (1 variants)
- Rare_genetic_intellectual_disability (1 variants)
- Neurodevelopmental_abnormality (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the WAC gene is commonly pathogenic or not. These statistics are base on transcript: NM_000016628.5. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 14 | 19 | ||||
| missense | 118 | 27 | 152 | |||
| nonsense | 24 | 34 | ||||
| start loss | 0 | |||||
| frameshift | 49 | 10 | 61 | |||
| splice donor/acceptor (+/-2bp) | 20 | |||||
| Total | 83 | 26 | 127 | 41 | 9 |
Highest pathogenic variant AF is 0.0000013803118
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| WAC | protein_coding | protein_coding | ENST00000354911 | 14 | 90620 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 1.00 | 0.00000294 | 124747 | 0 | 4 | 124751 | 0.0000160 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 1.51 | 262 | 341 | 0.769 | 0.0000171 | 4199 |
| Missense in Polyphen | 78 | 125.17 | 0.62317 | 1639 | ||
| Synonymous | -0.416 | 133 | 127 | 1.05 | 0.00000714 | 1270 |
| Loss of Function | 5.53 | 0 | 35.6 | 0.00 | 0.00000196 | 405 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.00 | 0.00 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.000112 | 0.000110 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.0000183 | 0.0000177 |
| Middle Eastern | 0.000112 | 0.000110 |
| South Asian | 0.00 | 0.00 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Acts as a linker between gene transcription and histone H2B monoubiquitination at 'Lys-120' (H2BK120ub1) (PubMed:21329877). Interacts with the RNA polymerase II transcriptional machinery via its WW domain and with RNF20-RNF40 via its coiled coil region, thereby linking and regulating H2BK120ub1 and gene transcription (PubMed:21329877). Regulates the cell-cycle checkpoint activation in response to DNA damage (PubMed:21329877). Positive regulator of amino acid starvation- induced autophagy (PubMed:22354037). Also acts as a negative regulator of basal autophagy (PubMed:26812014). Positively regulates MTOR activity by promoting, in an energy-dependent manner, the assembly of the TTT complex composed of TELO2, TTI1 and TTI2 and the RUVBL complex composed of RUVBL1 and RUVBL2 into the TTT-RUVBL complex. This leads to the dimerization of the mTORC1 complex and its subsequent activation (PubMed:26812014). May negatively regulate the ubiquitin proteasome pathway (PubMed:21329877). {ECO:0000269|PubMed:21329877, ECO:0000269|PubMed:22354037, ECO:0000269|PubMed:26812014}.;
- Disease
- DISEASE: DeSanto-Shinawi syndrome (DESSH) [MIM:616708]: An autosomal dominant syndrome characterized by developmental delay, hypotonia, behavioral problems, eye abnormalities, constipation, feeding difficulties, seizures and sleep problems. Patients exhibit dysmorphic features, including broad/prominent forehead, synophrys and/or bushy eyebrows, depressed nasal bridge and bulbous nasal tip. Additional variable features are posteriorly rotated ears, hirsutism, deep-set eyes, thin upper lip, inverted nipples, hearing loss and branchial cleft anomalies. {ECO:0000269|PubMed:25356899, ECO:0000269|PubMed:26264232}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Defects in WAC are the cause of a form of intellectual disability characterized by hypotonia, behavioral problems and distinctive facial dysmorphisms including a square- shaped face, deep set eyes, long palpebral fissures, and a broad mouth and chin. {ECO:0000269|PubMed:26757981}.;
- Pathway
- Post-translational protein modification;Metabolism of proteins;Protein ubiquitination;E3 ubiquitin ligases ubiquitinate target proteins
(Consensus)
Recessive Scores
- pRec
- 0.125
Intolerance Scores
- loftool
- 0.325
- rvis_EVS
- -0.87
- rvis_percentile_EVS
- 10.73
Haploinsufficiency Scores
- pHI
- 0.238
- hipred
- Y
- hipred_score
- 0.673
- ghis
- 0.659
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.466
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Wac
- Phenotype
Gene ontology
- Biological process
- cellular response to DNA damage stimulus;histone monoubiquitination;positive regulation of macroautophagy;protein ubiquitination;negative regulation of proteasomal ubiquitin-dependent protein catabolic process;G1 DNA damage checkpoint;positive regulation of transcription, DNA-templated;histone H2B conserved C-terminal lysine ubiquitination
- Cellular component
- nucleus;nucleoplasm;spliceosomal complex;nuclear speck
- Molecular function
- RNA polymerase II complex binding;chromatin binding;protein binding